High calibre research advanced by NHMRC funding

03 December 2016
Dr Samir Taoudi receives $1 million from the NHMRC to support blood cells studies
Improved treatments for cancers, blood diseases, asthma and inflammatory bowel diseases are among the goals of Walter and Eliza Hall Institute scientists who have received grants in the latest round of the National Health and Medical Research Council of Australia (NHMRC) funding.

WEHI has received $31.9 million in support of project grants and fellowships across a range of research areas including immunology, infectious diseases, cancer, systems biology, and personalised medicine.

Among the grant recipients, Dr Samir Taoudi received $1 million that will support his team’s research into how blood cells are formed.

One of the funded projects will investigate how to make blood stem cells, which are used to treat people whose own blood forming systems have failed. This research will also uncover the differences in blood functions between children and adults, with a goal of informing the tailoring of blood product therapies for children with blood disorders.

Dr Taoudi said the new funding would enable the team to make urgently needed advances in the laboratory-based production of blood.

“This research will directly address the question of how best to treat babies who are born with dangerously low numbers of platelets, the cells that allow their blood to clot,” Dr Taoudi said.

Samir Taoudi is a member of the Stem Cells Australia initiative.